| abstract |
The present invention relates to the use of 1H-imidazo [4,5-c] quinolinone compounds and salts thereof for the treatment of proteins and / or lipid kinase dependent diseases and the manufacture of pharmaceutical formulations for the treatment of the diseases; Or administration of a 1H-imidazo [4,5-c] quinolinone compound; 1H-imidazo [4,5-c] quinolinone compound for use in the treatment of lipid kinase dependent diseases to warm-blooded animals, particularly humans. A method of treating the disease comprising: a pharmaceutical preparation comprising a 1H-imidazo [4,5-c] quinolinone compound, in particular for the treatment of protein and / or lipid kinase dependent diseases; a novel 1H-imidazo [4,5-c A quinolinone compound; and a process for producing a novel 1H-imidazo [4,5-c] quinolinone compound. |